These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 15610306)

  • 1. Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus-related chronic liver disease.
    Fujiwara K; Tanaka Y; Orito E; Ohno T; Kato T; Sugauchi F; Suzuki S; Hattori Y; Sakurai M; Hasegawa I; Ozasa T; Kanie F; Kano H; Ueda R; Mizokami M
    J Gastroenterol Hepatol; 2004 Dec; 19(12):1343-7. PubMed ID: 15610306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
    Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver enzyme flares and occult hepatitis B in persons with chronic hepatitis C infection.
    Kannangai R; Vivekanandan P; Netski D; Mehta S; Kirk GD; Thomas DL; Torbenson M
    J Clin Virol; 2007 Jun; 39(2):101-5. PubMed ID: 17452002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis.
    Motta JS; Mello FC; Lago BV; Perez RM; Gomes SA; Figueiredo FF
    J Gastroenterol Hepatol; 2010 Jan; 25(1):101-6. PubMed ID: 19817965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.
    Azadmanesh K; Mohraz M; Aghakhani A; Edalat R; Jam S; Eslamifar A; Banifazl M; Moradmand-Badie B; Ramezani A
    Intervirology; 2008; 51(4):270-4. PubMed ID: 18841029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult HBV infection in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Sav T; Gursoy S; Torun E; Sav NM; Unal A; Oymak O; Utas C
    Ren Fail; 2010 Jan; 32(1):74-7. PubMed ID: 20113270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan.
    Toyoda H; Hayashi K; Murakami Y; Honda T; Katano Y; Nakano I; Goto H; Kumada T; Takamatsu J
    J Med Virol; 2004 Jun; 73(2):195-9. PubMed ID: 15122792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overt and hidden coinfection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda.
    Stránský J; Malina L; Cieslarová B; Stríteský J; Půtová I; Horák J
    Acta Virol; 2000 Feb; 44(1):23-8. PubMed ID: 10989688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
    Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ
    J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of occult hepatitis B virus in chronic hepatitis C patients with flare of liver enzymes.
    Selim HS; Abou-Donia HA; Taha HA; El Azab GI; Bakry AF
    Eur J Intern Med; 2011 Apr; 22(2):187-90. PubMed ID: 21402251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection.
    Squadrito G; Orlando ME; Pollicino T; Raffa G; Restuccia T; Cacciola I; Di Marco V; Picciotto A; Colucci G; Craxì A; Raimondo G
    Am J Gastroenterol; 2002 Jun; 97(6):1518-23. PubMed ID: 12094876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of occult hepatitis B in Baltimore injection drug users.
    Torbenson M; Kannangai R; Astemborski J; Strathdee SA; Vlahov D; Thomas DL
    Hepatology; 2004 Jan; 39(1):51-7. PubMed ID: 14752822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C.
    Shetty K; Hussain M; Nei L; Reddy KR; Lok AS
    Liver Transpl; 2008 Apr; 14(4):534-40. PubMed ID: 18324677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey.
    Yalcin K; Degertekin H; Bahcecioglu IH; Demir A; Aladag M; Yildirim B; Horasanli S; Ciftci S; Badur S
    Infection; 2004 Feb; 32(1):24-9. PubMed ID: 15007739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
    Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Bartolomé J; Pardo M; Carreño V
    J Med Virol; 2007 Mar; 79(3):236-41. PubMed ID: 17245725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult hepatitis B virus infection in hemodialysis patients with chronic HCV infection.
    Siagris D; Christofidou M; Triga K; Pagoni N; Theocharis GJ; Goumenos D; Lekkou A; Thomopoulos K; Tsamandas AC; Vlachojannis J; Labropoulou-Karatza C
    J Nephrol; 2006; 19(3):327-33. PubMed ID: 16874693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine deaminase activity in serum of patients with hepatitis -- a useful tool in monitoring clinical status.
    Kaya S; Cetin ES; Aridogan BC; Arikan S; Demirci M
    J Microbiol Immunol Infect; 2007 Aug; 40(4):288-92. PubMed ID: 17712462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.